MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group.

医学 冲程(发动机) 随机对照试验 动脉内膜切除术 外科 狭窄 颈动脉内膜切除术 心脏病学 机械工程 工程类
作者
Troels S. Jensen
出处
期刊:PubMed 卷期号:337 (8752): 1235-43 被引量:964
链接
标识
摘要

The European Carotid Surgery Trial is a multicentre trial of carotid endarterectomy for patients who, after a carotid territory non-disabling ischaemic stroke, transient ischaemic attack, or retinal infarct, are found to have a stenotic lesion in the relevant (ipsilateral) carotid artery. Over the past 10 years 2518 patients have been randomised, and the mean follow-up is now almost 3 years among the 2200 thus far available for analysis of the incidence of strokes that lasted more than 7 days. For the patients with "moderate" (30-69%) stenosis on their prerandomisation angiogram the balance of surgical risk and eventual benefit remains uncertain, and full recruitment continues. For 374 patients with only "mild" (0-29%) stenosis there was little 3-year risk of ipsilateral ischaemic stroke, even in the absence of surgery, so any 3-year benefits of surgery were small, and were outweighed by its early risks. For 778 patients with "severe" (70-99%) stenosis, however, the risks of surgery were significantly outweighed by the later benefits: although 7.5% had a stroke (or died) within 30 days of surgery, during the next 3 years the risks of ipsilateral ischaemic stroke were (by life-table analysis) an extra 2.8% for surgery-allocated and 16.8% for control patients (a sixfold reduction, p less than 0.0001). There was also a small reduction in other strokes, and at 3 years the total risk of surgical death, surgical stroke, ipsilateral ischaemic stroke, or any other stroke was 12.3% for surgery and 21.9% for control (difference 9.6% SD 3.3, 2p less than 0.01). The main concern was to avoid disabling or fatal events, and, among severe stenosis patients, 3.7% had a disabling stroke (or died) within 30 days of surgery, an extra 1.1% surgery versus 8.4% control (p less than 0.0001) had a disabling or fatal ipsilateral ischaemic stroke by 3 years, and the total 3-year risk of any disabling or fatal stroke (or surgical death) was 6.0% surgery versus 11.0% control (overall difference 5.0% SD 2.3, 2p less than 0.05); but, for disabling or fatal stroke the control risks seemed to diminish after the first year, so delay of surgery by just a few months after clinical presentation might make this overall difference non-significant.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
研友_VZG7GZ应助东方耀采纳,获得10
1秒前
1秒前
大卫完成签到,获得积分10
2秒前
小屁孩发布了新的文献求助10
2秒前
2秒前
ding应助djbj2022采纳,获得10
2秒前
赘婿应助WWW采纳,获得10
2秒前
3秒前
dtf完成签到,获得积分10
3秒前
3秒前
3秒前
3秒前
落枫流年完成签到,获得积分10
3秒前
3秒前
深情新之发布了新的文献求助10
3秒前
Amen完成签到,获得积分10
5秒前
5秒前
5秒前
Binggo发布了新的文献求助10
5秒前
在水一方应助wos采纳,获得10
5秒前
5秒前
6秒前
爱蕊咖完成签到 ,获得积分10
6秒前
大个应助猫猫采纳,获得10
6秒前
8秒前
春风十里完成签到,获得积分10
8秒前
Lucas应助钟D摆采纳,获得10
8秒前
LLXY完成签到,获得积分10
8秒前
科研助手6应助johnnwick采纳,获得10
8秒前
思源应助北岛采纳,获得10
8秒前
JY发布了新的文献求助10
9秒前
jerry完成签到,获得积分10
9秒前
9秒前
10秒前
10秒前
阔达的语海完成签到,获得积分10
10秒前
小田发布了新的文献求助10
10秒前
勤奋的丸子完成签到,获得积分10
10秒前
共享精神应助1282941496采纳,获得10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969383
求助须知:如何正确求助?哪些是违规求助? 3514211
关于积分的说明 11172730
捐赠科研通 3249476
什么是DOI,文献DOI怎么找? 1794909
邀请新用户注册赠送积分活动 875441
科研通“疑难数据库(出版商)”最低求助积分说明 804827